Viereck V - Search Results

1

Nd:YAG/Er:YAG dual laser compared with topical steroid to treat vulvar lichen sclerosus: A randomised controlled trial.

Zivanovic I, Gamper M, Fesslmeier D, Walser C, Regauer S, Viereck V. Zivanovic I, et al. Among authors: viereck v. BJOG. 2024 May;131(6):740-749. doi: 10.1111/1471-0528.17737. Epub 2023 Dec 27. BJOG. 2024. PMID: 38149520 Clinical Trial.

2

Nd:YAG/Er:YAG dual laser vs. topical steroid to treat vulvar lichen sclerosus: study protocol of a randomized controlled trial.

Viereck V, Gamper M, Regauer S, Walser C, Zivanovic I. Viereck V, et al. Arch Gynecol Obstet. 2023 Aug;308(2):643-649. doi: 10.1007/s00404-023-07055-z. Epub 2023 May 5. Arch Gynecol Obstet. 2023. PMID: 37145134 Free PMC article.

3

Correction: Nd:YAG/Er:YAG dual laser vs. topical steroid to treat vulvar lichen sclerosus: study protocol of a randomized controlled trial.

Viereck V, Gamper M, Regauer S, Walser C, Zivanovic I. Viereck V, et al. Arch Gynecol Obstet. 2024 Jan;309(1):339-340. doi: 10.1007/s00404-023-07162-x. Arch Gynecol Obstet. 2024. PMID: 37874354 Free PMC article. No abstract available.

4

Erbium:YAG laser treatment of female stress urinary incontinence: midterm data.

Kuszka A, Gamper M, Walser C, Kociszewski J, Viereck V. Kuszka A, et al. Among authors: viereck v. Int Urogynecol J. 2020 Sep;31(9):1859-1866. doi: 10.1007/s00192-019-04148-9. Epub 2019 Dec 11. Int Urogynecol J. 2020. PMID: 31828400

5

Combination therapy with botulinum toxin and bulking agent-An efficient, sustainable, and safe method to treat elderly women with mixed urinary incontinence.

Viereck V, Gamper M, Walser C, Fesslmeier D, Münst J, Zivanovic I. Viereck V, et al. Neurourol Urodyn. 2021 Sep;40(7):1820-1828. doi: 10.1002/nau.24757. Epub 2021 Aug 3. Neurourol Urodyn. 2021. PMID: 34342363 Free PMC article.

6

Urethral bulking for recurrent stress urinary incontinence after midurethral sling failure.

Zivanovic I, Rautenberg O, Lobodasch K, von Bünau G, Walser C, Viereck V. Zivanovic I, et al. Among authors: viereck v. Neurourol Urodyn. 2017 Mar;36(3):722-726. doi: 10.1002/nau.23007. Epub 2016 Mar 31. Neurourol Urodyn. 2017. PMID: 27037856 Free article.

7

Sensory Hyperinnervation Distinguishes Bladder Pain Syndrome/Interstitial Cystitis from Overactive Bladder Syndrome.

Regauer S, Gamper M, Fehr MK, Viereck V. Regauer S, et al. Among authors: viereck v. J Urol. 2017 Jan;197(1):159-166. doi: 10.1016/j.juro.2016.06.089. Epub 2016 Jul 1. J Urol. 2017. PMID: 27378135

8

Role of intrinsic sphincter deficiency with and without urethral hypomobility on the outcome of tape insertion.

Wlaźlak E, Viereck V, Kociszewski J, Kuszka A, Rautenberg O, Walser C, Surkont G, Gamper M, Fehr MK. Wlaźlak E, et al. Among authors: viereck v. Neurourol Urodyn. 2017 Sep;36(7):1910-1916. doi: 10.1002/nau.23211. Epub 2017 Jan 31. Neurourol Urodyn. 2017. PMID: 28139863

9

Re: Sheng W, Zhang H, Kirschner-Hermanns R. Could urinary nerve growth factor be a biomarker for overactive bladder? A meta-analysis. Neurourol Urodyn. 2017;9999:1-8. doi: 10.1002/nau.23210.

Gamper M, Viereck V. Gamper M, et al. Among authors: viereck v. Neurourol Urodyn. 2017 Nov;36(8):2190-2191. doi: 10.1002/nau.23268. Epub 2017 Mar 27. Neurourol Urodyn. 2017. PMID: 28346713

10

Current Treatment Concepts for Stress Urinary Incontinence.

Rautenberg O, Zivanovic I, Kociszewski J, Kuszka A, Münst J, Eisele L, Viereck N, Walser C, Gamper M, Viereck V. Rautenberg O, et al. Among authors: viereck v, viereck n. Praxis (Bern 1994). 2017 Nov 16;106(15):829e-836e. doi: 10.1024/1661-8157/a002843. Praxis (Bern 1994). 2017. PMID: 29143573 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters